The Nigerian Communications Commission (NCC) has approved a 50% tariff increase for telecom operators, raising the cost of data and airtime for Nigerian subscribers. The adjustment, effective immediately, aims to address operational cost challenges faced by...
In a landmark move to safeguard the interests of telecommunications consumers, the Nigerian Communications Commission (NCC) and the Federal Competition and Consumer Protection Commission (FCCPC) have signed a Memorandum of Understanding (MoU) to foster regulatory collaboration....
EDITORIAL
Since the Spanish flu pandemic of 1918, otherwise known as the great influenza, the world has never witnessed a pandemic as threatening and...
Germany’s vaccine committee, known as STIKO, on Tuesday recommended using AstraZeneca’s COVID-19 vaccine only for people aged 60 and over following further reports of...
By Ismail Auwal
Cameroon has announced the suspension of the administration of AstraZeneca’s COVID-19 vaccine.
The health ministry was scheduled to receive the vaccine on March...
The EU’s drug watchdog said on Thursday it is still convinced the benefits of AstraZeneca’s COVID-19 vaccine outweigh the risks following an investigation into...
By Abba Gwale
Multiple experts say that the COVID-19 vaccine developed by Oxford University and pharmaceutical giant AstraZeneca is being unfairly targeted by EU countries,...
By Salim Yunusa
The National Primary Health Care Development Agency has released a press statement on concerns about the safety of the Oxford/AstraZeneca Vaccine.
This is...
Denmark is suspending the use of the Oxford-AstraZeneca vaccine for 14 days as it investigates reports of some patients developing blood clots after being...
The clinical trial participants who were evaluated were relatively young and unlikely to become severely ill, making it impossible for the scientists to determine...
By Abba Gwale
The Indian drug regulatory body has approved COVID-19 vaccine developed by AstraZeneca and Oxford University for emergency use.
This endorsement follows initial authorisations...
Britain on Wednesday became the first country to authorize an easy-to-handle COVID-19 vaccine whose developers hope it will become the “vaccine for the world.”...
